Atsushi Usami is a Partner and Board Director at UTEC - The University of Tokyo Edge Capital Partners, holding this position since July 2020, and has been involved with UTEC portfolio companies from the seed and early stages, including Repertoire Genesis Inc. and OriCiro Genomics, Inc. Previously, Atsushi worked as a Researcher at Mitsubishi Research Institute from April 2012 to October 2013, focusing on projects related to pharmaceutical and medical device companies, as well as consulting for government agencies. Atsushi holds a Ph.D. in Pharmaceutical Sciences from The University of Tokyo, earned between April 2007 and March 2012.